Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy

Nele Adriaenssens, Vincent Vinh-Hung, Geertje Miedema, Harijati Versmessen, Jan Lamote, Marian Vanhoeij, Pierre Lievens, Hilde van Parijs, Guy Storme, Mia Voordeckers, Mark De Ridder, Nele Adriaenssens, Vincent Vinh-Hung, Geertje Miedema, Harijati Versmessen, Jan Lamote, Marian Vanhoeij, Pierre Lievens, Hilde van Parijs, Guy Storme, Mia Voordeckers, Mark De Ridder

Abstract

Introduction: Shoulder/arm morbidity is a common complication of breast cancer surgery and radiotherapy (RT), but little is known about acute contralateral morbidity.

Methods: Patients were 118 women enrolled in a RT trial. Arm volume and shoulder mobility were assessed before and 1-3 months after RT. Correlations and linear regression were used to analyze changes affecting ipsilateral and contralateral arms, and changes affecting relative interlimb differences (RID).

Results: Changes affecting one limb correlated with changes affecting the other limb. Arm volume between the two limbs correlated (R = 0.57). Risk factors were weight increase and axillary dissection. Contralateral and ipsilateral loss of abduction strongly correlated (R = 0.78). Changes of combined RID exceeding 10% affected the ipsilateral limb in 25% of patients, and the contralateral limb in 18%. Aromatase inhibitor therapy was significantly associated with contralateral loss of abduction.

Conclusions: High incidence of early contralateral arm morbidity warrants further investigations.

Keywords: breast cancer-related lymphedema; early breast cancer; image-guided radiation therapy; short-course radiation therapy; shoulder/arm morbidity.

Figures

Figure 1
Figure 1
Distributions of the pre- to post-radiotherapy changes (Δ) of the relative interlimb differences (RID).
Figure 2
Figure 2
Correlations among ipsilateral shoulder-arm changes. Notes: ΔI. = changes observed on the ipsilateral limb after breast radiotherapy, for measurements of abduction (abd.), retroflexion (retroflx.), anteflexion (anteflx.), endorotation (endo.), scapular distance (sc.dist.), and volume (vol.). Ellipses: 95% confidence density. Red colored ellipses indicate statistically significant correlations (P ≤ 0.05).
Figure 3
Figure 3
Correlations among contralateral shoulder-arm changes. Notes: ΔC. = changes observed on the contralateral limb after breast radiotherapy, for measurements of abduction (abd.), retroflexion (retroflx.), anteflexion (anteflx.), endorotation (endo.), scapular distance (sc.dist.), and volume (vol.). Ellipses: 95% confidence density. Red colored ellipses indicate statistically significant correlations (P ≤ 0.05).
Figure 4
Figure 4
Correlations between ipsilateral and contralateral shoulder-arm changes. Notes: Changes observed on the ipsilateral (ΔI.) and contralateral (ΔC.) limb after breast radiotherapy, for measurements of abduction (abd.), retroflexion (retroflx.), anteflexion (anteflx.), endorotation (endo.), scapular distance (sc.dist.), and volume (vol.). Ellipses: 95% confidence density. Red colored ellipses indicate statistically significant correlations (P ≤ 0.05).
Figure 5
Figure 5
Distribution of volume relative interlimb difference (RID) at baseline and after radiotherapy (RT). Notes: Top graph: At baseline pre-radiotherapy, 21% of the patients presented with limb edema, as defined by a volume RID of ≥5%. These patients are represented as blue bars. Bottom graph: Pre-radiotherapy, some patients improved (shift of the blue bars toward 0), some worsened (increase up to RID > 30). The dark green bars are patients who had no ipsilateral limb edema at baseline. The net result Pre-radiotherapy is an incidence of 24% patients with ipsilateral limb edema, composed of patients who had persistent edema (blue), minus those whose edema resolved, but incremented by patients with new onset of ipsilateral edema (dark green). Conversely, at baseline 17% of the patients presented with contralateral limb edema, shown as brown bars. Pre-radiotherapy, the incidence of contralateral limb edema is 18%. The 18% is composed of patients with prior contralateral edema that did not resolve (brown), incremented by patients with new onset of contralateral edema (yellow).

References

    1. Boyle P, Levin B, editors. International Agency for Research on Cancer. World cancer report. Lyon, France: International Agency for Research on Cancer; 2008.
    1. National Cancer Institute. SEER Cancer Statistics Review 1975–2008. In: Howlader N, Noone A, Krapcho M, et al., editors. Based on November 2010 SEER data submission, posted to the SEER web site. Bethesda, MD: 2011.
    1. Lee TS, Kilbreath SL, Refshauge KM, Herbert RD, Beith JM. Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat. 2008;110:19–37.
    1. Levangie PK, Drouin J. Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat. 2009;116:1–15.
    1. Shah C, Vicini FA. Breast Cancer-Related Arm Lymphedema: Incidence Rates, Diagnostic Techniques, Optimal Management and Risk Reduction Strategies. Int J Radiat Oncol Biol Phys. 2011
    1. Mortimer PS. The pathophysiology of lymphedema. Cancer. 1998;83:2798–802.
    1. Bentzen SM, Dische S. Morbidity related to axillary irradiation in the treatment of breast cancer. Acta Oncol. 2000;39:337–47.
    1. Arrault M, Vignes S. Risk factors for developing upper limb lymphedema after breast cancer treatment. Bull Cancer. 2006;93:1001–6.
    1. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16:1959–72.
    1. Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer. 2011;19:853–7.
    1. Tengrup I, Tennvall-Nittby L, Christiansson I, Laurin M. Arm morbidity after breast-conserving therapy for breast cancer. Acta Oncol. 2000;39:393–7.
    1. Haines TP, Sinnamon P. Early arm swelling after breast surgery: changes on both sides. Breast Cancer Res Treat. 2007;101:105–2.
    1. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v30 (CTCAE) National Cancer Institute; 2006.
    1. Voordeckers M, Van de Steene J, Vinh-Hung V, Storme G. Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative (pN0) breast cancer: is it worth the effort? Radiother Oncol. 2003;68:227–31.
    1. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol. 2004;70:225–30.
    1. Reynders T, Tournel K, De CP, et al. Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments. Radiother Oncol. 2009;93:71–9.
    1. Sitzia J. Volume measurement in lymphoedema treatment: examination of formulae. Eur J Cancer Care (Engl) 1995;4:11–6.
    1. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther. 2003;83:134–45.
    1. Meijer RS, Rietman JS, Geertzen JH, Bosmans JC, Dijkstra PU. Validity and intra-and interobserver reliability of an indirect volume measurements in patients with upper extremity lymphedema. Lymphology. 2004;37:127–33.
    1. Esch D, Lepley M. Evaluation of Joint Motion: Methods of Measurement and Recording. Minneapolis: University of Minnesota Press; 1974.
    1. Eston RG, Reilly T. Part two: neuromuscular and goniometric aspects of movement, 6. Flexibility. Kinanthropometry and Exercise Physiology Laboratory Manual: Tests, Procedure and Data. 1990:115–21.
    1. Duff M, Hill AD, McGreal G, Walsh S, McDermott EW, O’Higgins NJ. Prospective evaluation of the morbidity of axillary clearance for breast cancer. Br J Surg. 2001;88:114–7.
    1. Cho J, Han W, Lee JW, et al. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems. Ann Surg Oncol. 2008;15:2278–86.
    1. Husted Madsen A, Haugaard K, Soerensen J, et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast. 2008;17:138–47.
    1. Nesvold IL, Dahl AA, Lokkevik E, Marit MA, Fossa SD. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008;47:835–42.
    1. Shamley D, Srinaganathan R, Oskrochi R, Lascurain-Aguirrebena I, Sugden E. Three-dimensional scapulothoracic motion following treatment for breast cancer. Breast Cancer Res Treat. 2009;118:315–22.
    1. Chan DN, Lui LY, So WK. Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: systematic review. J Adv Nurs. 2010;66:1902–4.
    1. Crosbie J, Kilbreath SL, Dylke E, et al. Effects of mastectomy on shoulder and spinal kinematics during bilateral upper-limb movement. Phys Ther. 2010;90:679–92.
    1. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98:343–8.
    1. Gartner R, Jensen MB, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment—a nationwide study of prevalence and associated factors. Breast. 2010;19:506–15.
    1. Helms G, Kuhn T, Moser L, Remmel E, Kreienberg R. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection—data from a prospective randomised trial. Eur J Surg Oncol. 2009;35:696–701.
    1. Lievens P. Lymphedema or swelling? Journal of Lymphoedema. 2008;3:17–9.
    1. Nesvold IL, Fossa SD, Naume B, Dahl AA. Kwan’s arm problem scale: psychometric examination in a sample of stage II breast cancer survivors. Breast Cancer Res Treat. 2009;117:281–8.
    1. Boyd BS. Common Interlimb Asymmetries and Neurogenic Responses during Upper Limb Neurodynamic Testing: Implications for Test Interpretation. J Hand Ther. 2012;25:56–64.
    1. Burnham KP, Anderson DR. Multimodel inference: understanding AIC and BIC in model selection. Sociological Methods and Research. 2004;33:261–304.
    1. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. The Annals of Statistics. 2001;29:1165–88.
    1. The R Foundation for Statistical Computing. R version 2.14.1 (2011-12-22) The Comprehensive R Archive Network. Dec, 2011. [Accessed January 4, 2012.]. Available at: .
    1. Voordeckers M, Vinh-Hung V, Lamote J, Bretz A, Storme G. Survival benefit with radiation therapy in node-positive breast carcinoma patients. Strahlenther Onkol. 2009;185:656–62.
    1. Adriaenssens N, Van Parijs H, Miedema G, et al. Preliminary analysis of a randomized clinical trial comparing shoulder-arm morbidity between early breast cancer patients treated with short course image guided radiation therapy and conventional post surgery radiation therapy. The Journal of Breast Health. 2012
    1. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809–19.
    1. Perre CI, Hoefnagel CA, Kroon BB, Zoetmulder FA, Rutgers EJ. Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg. 1996;83:1258.
    1. Fontaine C, Adriaenssens N, Van Parijs H, et al. A propsective analysis of the incidence of breast cancer related lymphedema of the arm after surgery and axillary lymph node dissection in early breast cancer patients treated with concomitant irradiation and anthracyclines followed by paclitaxel. European Journal of Lymphology. 2011;22:20–4.
    1. Caers J, Fontaine C, Vinh-Hung V, et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer. 2005;13:325–31.
    1. Smoot B, Wong J, Cooper B, et al. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv. 2010;4:167–78.
    1. Dent SF, Gaspo R, Kissner M, Pritchard KI. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res Treat. 2011;126:295–310.
    1. Borstad JD. Resting position variables at the shoulder: evidence to support a posture-impairment association. Phys Ther. 2006;86:549–57.
    1. Rostkowska E, Bak M, Samborski W. Body posture in women after mastectomy and its changes as a result of rehabilitation. Adv Med Sci. 2006;51:287–97.
    1. Malicka I, Barczyk K, Hanuszkiewicz J, Skolimowska B, Wozniewski M. Body posture of women after breast cancer treatment. Ortop Traumatol Rehabil. 2010;12:353–61.
    1. Ebaugh D, Spinelli B, Schmitz KH. Shoulder impairments and their association with symptomatic rotator cuff disease in breast cancer survivors. Med Hypotheses. 2011;77:481–7.
    1. Beurskens CH, van Uden CJ, Strobbe LJ, Oostendorp RA, Wobbes T. The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer. 2007;7:166.
    1. Werner RS, McCormick B, Petrek J, et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology. 1991;180:177–84.
    1. May S, Chance-Larsen K, Littlewood C, Lomas D, Saad M. Reliability of physical examination tests used in the assessment of patients with shoulder problems: a systematic review. Physiotherapy. 2010;96:179–90.
    1. Mayrovitz HN, Macdonald J, Davey S, Olson K, Washington E. Measurement decisions for clinical assessment of limb volume changes in patients with bilateral and unilateral limb edema. Phys Ther. 2007;87:1362–8.

Source: PubMed

Подписаться